SOFENIB 200 TABLET

Product Description

SOFENIB 200 TABLET is a premium-quality oncology medication containing Sorafenib 200mg, a potent multikinase inhibitor used in the treatment of advanced liver cancer (Hepatocellular Carcinoma), renal cell carcinoma (kidney cancer), and thyroid cancer. Formulated for targeted cancer therapy, this tablet disrupts tumor cell growth and angiogenesis, improving clinical outcomes in patients with late-stage cancers.

Engineered under WHO-GMP certified facilities, SOFENIB 200 is trusted by oncologists, hospital pharmacies, and cancer care institutions across India and global markets. It is ideal for pharmaceutical distributors, bulk buyers, and B2B oncology medicine suppliers looking for reliable, high-efficacy cancer drugs.

Key Benefits:

• Contains Sorafenib 200mg, an FDA-approved targeted therapy

• Effective in slowing tumor progression in liver, kidney, and thyroid cancers

• Manufactured under strict quality control and compliance standards

• Available in bulk quantities for hospitals, clinics, and resellers

Applications:

• First-line treatment for advanced hepatocellular carcinoma (HCC)

• Used in renal cell carcinoma (RCC) and differentiated thyroid carcinoma (DTC)

• Recommended in oncology departments and specialty care centers

Why Choose SOFENIB 200 TABLET?

• Proven efficacy in targeted cancer therapy

• Stable shelf life and secure packaging for distribution

• Preferred by B2B pharmaceutical buyers, medical institutions, and wholesalers